OrthoAccel® Technologies Inc, Bellaire, Texas, has named orthodontic specialist, Sonia Palleck, DDS, to its Key Opinion Leadership Group of clinicians who present scientific and clinical evidence supporting the company’s AcceleDent® technology. Now available in more than 1,000 orthodontic locations in North America, AcceleDent is the only FDA-cleared, Class II medical device designed to accelerate orthodontic treatment by as much as 50%.
Palleck owns Palleck Orthodontics in Woodstock and London, Ontario. She’s differentiated her practice by striving to accomplish all orthodontic cases in 12 months or less and, according to OrthoAccel, integrates AcceleDent into nearly all of her patients’ treatment plans to maximize clinical efficiency.
“I’m dedicated to providing patients the latest orthodontic techniques and technology. AcceleDent is a part of that strategy because I’ve seen it speed up treatment by as much as 30- to 40-percent, in addition to the reduction in time I’ve seen with Insignia alone, while also reducing patients’ discomfort,” Palleck said. “Treating people has always been a privilege that I treasure, and with AcceleDent it’s even more exciting because I’m giving patients the smile they’ve always wanted in half the time.”
A member of the American Association of Orthodontists and the Canadian Association of Orthodontists, Palleck has been in private practice more than 15 years and is a graduate clinical instructor of orthodontics at the University of Western Ontario.
